TPTF is an institutional investor (Conventional VCs) founded in 2014 and headquartered in Tokyo, Japan. Trans-Pacific Technology Fund(TPTF) is early to the growth stage venture capital investment company. Geographies of interest include Asia, North America, and Europe. Generally invests in tech startups operating in sectors such as Advanced materials, ICT, IOT, and robotics. Top investments include Apexigen, Clean Wave Technologies, Crown Biosciences, Kata.ai, MegaPro Biomedical. Notable portfolio companies: Apexigen, Clean Wave Technologies, Crown Biosciences, Kata.

Stage

early-stage to expansion/late-stage, early-stage to expansion/late-stage

Check size

$1M-$6M

HQ

Taipei, Taiwan

Founded

2014

Website

https://tptf.co

LinkedIn

https://linkedin.com/company/trans-pacific-technology-fund

What they look for

Disruptive platform technologies with daring entrepreneurs/great teams; global scope across Asia, North America, Europe; prioritizes Taiwan early-stage startups

Preparing to pitch TPTF?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.